← Open Payments lookup

GHISLAINE FOUGY: Open Payments

NPI 1689787079 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$506 in 24 payments from 8 companies in 2025. Trend: 2023 $192 · 2024 $252 · 2025 $506

Food & beverage: $506
CompanyPaymentsAmount
Alkermes, Inc.6$138
Teva Pharmaceuticals USA, Inc.4$73
Vanda Pharmaceuticals Inc.4$72
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$71
E.R. Squibb & Sons, L.L.C.3$68
Almatica Pharma LLC1$30
ABBVIE INC.2$29
Neurocrine BioSciences, Inc.1$24

Products named: ARISTADA, AUSTEDO XR, FANAPT, CAPLYTA, COBENFY, LOREEV XR, VRAYLAR, INGREZZA.

Industry payments across MD — which companies pay providers there.